CA21242-1 - 0x000000000000310C

Study Number: CA21242
Group Number: 1
Study Requirement: Healthy Male and Female
Stipend: $4,300.00

Study Criteria:

  • Age: 19 - 55
  • BMI: 18.5 - 32
  • Weight Restriction: minimum weight 0 lbs

Study Information:

  • Indication: This marketed medication is used to treat severe pain.
  • Route of Administration: Oral; Topical dermal transdermal
  • Blood Draws: 73

Study Schedule:

  • Schedule Type: Long Term
  • Study Length: Two - 4 Night Stays, One - 6 Night Stay & 1 Phone Call (courtesy stays available between visits)

Screening Dates: (appointments available in Lincoln and Omaha)

Event Day Event Date
Wednesday 10/25/2017
Thursday 10/26/2017

Doctor Exam Dates: (appointments available in Lincoln and Omaha)

Event Day Event Date
Wednesday 10/25/2017
Thursday 10/26/2017

Study Dates:

Event Type Start Day Start Date End Day End Date Phase Site
Check-In Monday 11/6/2017 2:00:00 PM Friday 11/10/2017 8:45:00 AM 1 Lincoln
Check-In Monday 11/13/2017 2:00:00 PM Friday 11/17/2017 9:00:00 AM 2 Lincoln
Check-In Monday 11/27/2017 2:00:00 PM Sunday 12/3/2017 9:00:00 AM 3 Lincoln
Phone participant* Saturday 12/16/2017 8:00:00 AM 3 Lincoln